The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand
· Delayed Price · Currency is THB 31.50
+0.25 (0.80%)
Mar 7, 2025, 4:36 PM ICT
BKK:KLINIQ Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 7, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 6,930 | 7,150 | 9,240 | 8,525 | - | - | Upgrade
|
| Market Cap Growth | -22.62% | -22.62% | 8.39% | - | - | - | Upgrade
|
| Enterprise Value | 6,810 | 7,093 | 8,436 | 8,748 | - | - | Upgrade
|
| Last Close Price | 31.50 | 32.50 | 40.45 | 36.30 | - | - | Upgrade
|
| PE Ratio | 21.51 | 22.19 | 32.01 | 41.49 | - | - | Upgrade
|
| Forward PE | 19.27 | 19.94 | - | - | - | - | Upgrade
|
| PS Ratio | 2.32 | 2.40 | 4.04 | 5.20 | - | - | Upgrade
|
| PB Ratio | 4.04 | 4.16 | 5.43 | 5.18 | - | - | Upgrade
|
| P/TBV Ratio | 4.18 | 4.18 | 5.44 | 5.19 | - | - | Upgrade
|
| P/FCF Ratio | - | - | 476.45 | 46.80 | - | - | Upgrade
|
| P/OCF Ratio | 12.95 | 12.95 | 23.94 | 20.90 | - | - | Upgrade
|
| EV/Sales Ratio | 2.28 | 2.38 | 3.69 | 5.34 | - | - | Upgrade
|
| EV/EBITDA Ratio | 10.00 | 12.82 | 15.63 | 26.59 | - | - | Upgrade
|
| EV/EBIT Ratio | 17.08 | 17.80 | 24.44 | 34.21 | - | - | Upgrade
|
| EV/FCF Ratio | -345.71 | - | 435.00 | 48.02 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.38 | 0.38 | 0.27 | 0.19 | 1.29 | 1.91 | Upgrade
|
| Debt / EBITDA Ratio | 0.97 | 0.97 | 0.85 | 0.77 | 0.88 | 0.86 | Upgrade
|
| Debt / FCF Ratio | - | - | 23.79 | 1.67 | 1.25 | 2.12 | Upgrade
|
| Asset Turnover | 1.00 | 1.00 | 0.84 | 0.96 | 1.20 | - | Upgrade
|
| Inventory Turnover | 6.23 | 6.23 | 6.75 | 7.01 | 4.18 | - | Upgrade
|
| Quick Ratio | 0.91 | 0.91 | 1.54 | 2.08 | 0.16 | 0.02 | Upgrade
|
| Current Ratio | 1.32 | 1.32 | 1.93 | 2.38 | 0.41 | 0.39 | Upgrade
|
| Return on Equity (ROE) | 18.84% | 18.84% | 17.24% | 22.75% | 95.13% | - | Upgrade
|
| Return on Assets (ROA) | 8.35% | 8.35% | 7.94% | 9.39% | 12.07% | - | Upgrade
|
| Return on Capital (ROIC) | 10.98% | 10.98% | 10.48% | 13.79% | 27.72% | - | Upgrade
|
| Return on Capital Employed (ROCE) | 17.69% | 17.69% | 16.60% | 13.57% | 48.59% | 60.43% | Upgrade
|
| Earnings Yield | 4.65% | 4.51% | 3.12% | 2.41% | - | - | Upgrade
|
| FCF Yield | -0.28% | -0.28% | 0.21% | 2.14% | - | - | Upgrade
|
| Dividend Yield | 4.44% | 4.31% | 3.21% | 1.38% | - | - | Upgrade
|
| Payout Ratio | 95.60% | 95.60% | 80.04% | 74.55% | 61.89% | 206.78% | Upgrade
|
| Buyback Yield / Dilution | - | -29.64% | -6.06% | - | -202.11% | Upgrade
| |
| Total Shareholder Return | 4.44% | 4.31% | -26.43% | -4.68% | - | -202.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.